Clinical Trial Update: A Study to Evaluate the Effect of of Albuterol Sulfate Inhalation Aerosol, eq 90 mcg Base (Sun Pharmaceuticals Industries Limited) [Phase 3]

View source ↗

Summary

Phase 3 study assessing albuterol sulfate inhalation aerosol (90 mcg) in asthma completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Albuterol sulfate inhalation aerosol (Sun Pharmaceuticals Industries Limited) 90 mcg base (albuterol sulfate)

Snippet

Sponsor: Sun Pharmaceutical Industries Limited | Conditions: Asthma | Phase 3 | Status: COMPLETED | Results posted: 2021-01-22